Abstract

Breaking barriers: bridging the gap in lung cancer trials through inclusive representation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide.
Jessica St Louis ... Adriana Barrichello
Journal of global oncology | VOL. 4
Jessica St Louis, et. al.Jessica St Louis ... Adriana Barrichello
11 Apr 2018
Representing cancer clinical trial criteria and attributes using ontologies: An NLP-assisted approach.
Xiaoyan Wang ... Kyeryoung Lee
Journal of Clinical Oncology | VOL. 38
Xiaoyan Wang, et. al.Xiaoyan Wang ... Kyeryoung Lee
20 May 2020
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
Sara M Mangsbo ... Steinar Aamdal
Journal for ImmunoTherapy of Cancer | VOL. 10
Sara M Mangsbo, et. al.Sara M Mangsbo ... Steinar Aamdal
01 May 2022
Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity.
Adam Fundytus ... Ajay Aggarwal
Current oncology (Toronto, Ont.) | VOL. 29
Adam Fundytus, et. al.Adam Fundytus ... Ajay Aggarwal
07 Apr 2022
View more papers

More From: AME Clinical Trials Review

Paper Title
Journal
Date
Author
Combination metronomic chemotherapy and immunotherapy in non-small cell lung cancer remains exploratory: the VinMetAtezo trial
Joel W Neal ... Fangdi Sun
AME Clinical Trials Review | VOL. 2
Joel W Neal, et. al.Joel W Neal ... Fangdi Sun
01 Apr 2024
Neoadjuvant osimertinib: a promising therapeutic option for locally advanced EGFR-mutant lung adenocarcinoma
Masaaki Sato ... Shinji Yuhara
AME Clinical Trials Review | VOL. 2
Masaaki Sato, et. al.Masaaki Sato ... Shinji Yuhara
01 Apr 2024
ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma
Leonardo Rojas ... Andrés F Cardona
AME Clinical Trials Review | VOL. 2
Leonardo Rojas, et. al.Leonardo Rojas ... Andrés F Cardona
01 Apr 2024
How to navigate an increasingly heterogeneous spectrum of resistance mechanisms in oncogene driven non-small cell lung cancer?
Charlotte De Bondt ... Paul Van Schil
AME Clinical Trials Review | VOL. 2
Charlotte De Bondt, et. al.Charlotte De Bondt ... Paul Van Schil
01 Apr 2024
View more papers